You get your bloodwork back. Total testosterone: 650 ng/dL. Solidly mid-range. Your doctor tells you everything looks fine. You feel like shit anyway—low drive, low energy, erections that are more suggestion than substance. So you start researching. You buy a testosterone booster. You take ashwagandha, tongkat ali, fenugreek. Maybe your total T bumps up a hundred points. You still feel like shit.
Here is what nobody told you: total testosterone is a storage number. Free testosterone is the active number. And the gap between them is determined by one protein that almost no one tests.
That protein is sex hormone-binding globulin. And it may be the single most important variable in your hormonal health that you have never heard of.
The Free Hormone Hypothesis: What Actually Counts
The free hormone hypothesis posits that only the unbound, free fraction of a hormone is biologically active at target tissues. The rest—the testosterone bound tightly to SHBG—is essentially cargo. It circulates in the bloodstream, it shows up on your lab report as “total testosterone,” but it cannot enter cells. It cannot activate androgen receptors. It cannot do anything.
Most testosterone in your blood is bound. Approximately 60–70% is tightly bound to SHBG, a glycoprotein produced primarily in the liver. Another 30–40% is loosely bound to albumin. Only about 1–2% circulates as free testosterone. That 1–2% is the fraction that matters.
This is not a theoretical distinction. A 2025 study published in Physiology examined men with supraphysiologic SHBG levels—above 100 nmol/L—and found that participants with low free testosterone, despite normal or elevated total testosterone, consistently exhibited elevated gonadotropins (FSH and/or LH). The researchers concluded that the hypothalamic-pituitary axis may primarily respond to free testosterone levels rather than total testosterone. Your own brain is reading the free fraction. So should you.
The clinical implications are profound. A man with a total T of 800 but an SHBG of 70 nmol/L may have a calculated free T of 8 ng/dL—functionally hypogonadal. A man with a total T of 450 but an SHBG of 15 nmol/L may have a free T of 12 ng/dL—functionally robust. The total T tells you almost nothing. The SHBG tells you almost everything.
What Raises SHBG (And Why You Should Care)
SHBG is not static. It rises and falls in response to a specific set of inputs, many of which are under your control.
Age: SHBG increases with age in men. This is one of the primary mechanisms of age-related androgen decline—not a drop in production, but an increase in binding.
Thyroid function: Hyperthyroidism raises SHBG. Hypothyroidism lowers it. Even subclinical thyroid dysfunction can shift the free androgen fraction.
Estrogen: Estrogen stimulates SHBG production in the liver. This is why conditions associated with estrogen excess—obesity (via aromatase), certain medications, endocrine disruptors—tend to raise SHBG.
Liver function: The liver produces SHBG. Fatty liver disease, alcohol consumption, and certain medications alter SHBG production.
Insulin: Insulin suppresses SHBG production. This is why metabolic syndrome and insulin resistance are associated with low SHBG. The relationship is bidirectional and complex.
Caloric restriction and low-carb diets: Both raise SHBG. This is a common reason why men on aggressive diets experience a paradoxical drop in libido and erectile function despite “getting healthier.”
The takeaway is that SHBG is a modifiable variable. And for men who have tried testosterone boosters without success, the problem is often that they are raising total T while SHBG is simultaneously rising to bind it. They are filling a bucket with a hole in the bottom.
Nettle Root: The SHBG Displacer
The most evidence-backed natural intervention for SHBG is stinging nettle root (Urtica dioica).
The mechanism is competitive binding. A 2020 study published in the Journal of Biological Chemistry identified a compound in nettle root extract—(-)3,4-divanillyltetrahydrofuran, or DVT—that binds to SHBG. The binding affinity is relatively low compared to testosterone, but the mechanism is the point: DVT occupies the SHBG binding site, displacing testosterone in the process. The study showed that DVT increased the activity of testosterone in a cell culture androgen reporter system by competitively displacing testosterone from SHBG.
In plain language: nettle root doesn’t lower SHBG. It blocks SHBG from binding testosterone. The result is more free testosterone in circulation, available to your tissues.
The evidence for nettle root in human trials is not as robust as the in vitro data. The studies are mostly small, and the effect sizes are modest. But the mechanism is plausible, the safety profile is excellent, and it is one of the few natural compounds with a documented interaction with SHBG at the molecular level.
Dose: 300–600 mg of root extract daily. It is often combined with saw palmetto, which provides additional 5-alpha reductase inhibition.
The important caveat: nettle root is not a magic bullet. It is a displacement agent. If your SHBG is chronically elevated due to thyroid dysfunction, liver disease, or estrogen excess, nettle root will not solve the root cause. It will provide a modest shift in the free fraction while the underlying driver continues.
Boron: The Trace Element That Moves the Free Fraction
Boron is the most evidence-supported supplement for lowering SHBG in humans—and it is almost entirely absent from the mainstream conversation about testosterone.
The evidence comes from a series of studies by Naghii and colleagues. In a 2011 study published in the Journal of Trace Elements in Medicine and Biology, eight healthy male volunteers received 10 mg/day of boron for seven days. The results were striking: free testosterone increased significantly, SHBG decreased, estradiol decreased, and DHT increased. The study also reported reductions in inflammatory markers including hs-CRP and TNF-α.
A companion study using a weekly dosing protocol—10 mg of boron once per week for four weeks—found similar but less pronounced effects, suggesting that daily dosing is more effective than weekly dosing for hormonal outcomes. An earlier study by the same research group examined boron supplementation in men and reported increases in free testosterone and decreases in SHBG and estradiol, with the effects appearing within the first week of supplementation.
The mechanism is not fully established, but the leading hypothesis is that boron interacts with SHBG at the binding site, displacing testosterone in a manner similar to nettle root’s DVT. Some research also suggests boron may inhibit steroid hormone metabolism pathways, including aromatase and 5-alpha reductase, which would explain the simultaneous decrease in estradiol and increase in DHT. Boron has also been shown to affect the metabolism of vitamin D and magnesium, both of which have downstream effects on hormonal regulation.
The effect sizes in the Naghii studies were meaningful but not dramatic. Free testosterone increased, but the sample sizes were tiny—eight men—and the duration was short. There is no large randomized controlled trial of boron and free testosterone. This is not Tier 1 evidence. It is Tier 2 at best—mechanistically plausible, human data present, but methodologically limited.
Dose: 3–10 mg/day of boron (as boron citrate, boron glycinate, or boric acid). The 10 mg dose used in the Naghii studies is at the upper end of what is typically recommended. Higher doses—above 20 mg/day—carry risks of toxicity, including nausea, dermatitis, and reproductive effects in animal models. Boron has a narrow therapeutic window. It is not a compound to megadose.
The verdict: Boron has direct human evidence for lowering SHBG and increasing free testosterone. It is cheap, widely available, and has an excellent safety profile at the doses studied. It is one of the two most evidence-backed natural interventions for the free fraction—and the other is nettle root.
Beyond Nettle Root and Boron: What Else Moves the Free Fraction
If the goal is to increase free testosterone, the interventions must address the variables that determine SHBG levels and the variables that determine total T production.
Magnesium: A 2011 trial by Cinar and colleagues found that 200–400 mg/day of magnesium (as magnesium chloride) lowered SHBG and increased free testosterone in both sedentary and physically active men. This is one of the few supplements with direct human evidence for SHBG reduction.
Thyroid optimization: If SHBG is elevated due to thyroid dysfunction, addressing the thyroid is the first-line intervention.
Insulin sensitivity: If SHBG is low due to insulin resistance, improving metabolic health is the intervention. The relationship is bidirectional—insulin suppresses SHBG production, and low SHBG predicts insulin resistance.
Liver health: The liver produces SHBG. Fatty liver disease, alcohol consumption, and certain medications alter SHBG production. Addressing these drivers is foundational.
Vitamin D: Boron affects vitamin D metabolism, and vitamin D status is associated with testosterone levels. The two may interact. Maintaining adequate vitamin D is part of the foundation.
The Practical Protocol
If you are a man who has tried testosterone boosters without success, the protocol should be sequenced rather than stacked.
Step 1: Test the right things. Ask for total testosterone, SHBG, and calculated free testosterone. If your doctor refuses, find one who will. The free androgen index (total T / SHBG × 100) is a crude proxy, but calculated free T using the Vermeulen equation is the clinical standard.
Step 2: Address the drivers. If SHBG is high, look for the cause—thyroid, estrogen, liver, caloric restriction. If SHBG is low, look at insulin resistance and metabolic health.
Step 3: Add the displacers. Nettle root (300–600 mg/day) and boron (3–10 mg/day) are the two most evidence-supported supplements for increasing the free fraction. Magnesium (200–400 mg/day) has human trial data as well.
Step 4: Optimize total T production. Diet, exercise, sleep, and stress management remain the foundation. Ashwagandha, tongkat ali, and fenugreek can support production—but they are only half the equation if SHBG is binding what you produce.
Step 5: Cycle the displacers. The evidence for boron and nettle root is based on short-term studies. There is no data on chronic, indefinite use. Cycling—8–12 weeks on, 2–4 weeks off—is a reasonable precaution until longer-term data exist.
The Bottom Line
Total testosterone is the headline. Free testosterone is the story. SHBG is the mechanism that determines the difference.
If your total T is “normal” but you feel like shit, the problem may not be your production. It may be your binding. Nettle root and boron are the most evidence-backed natural interventions for displacing SHBG and increasing the free fraction. Boron has direct human data. Nettle root has a documented molecular mechanism. Magnesium has human trial data.
The man who understands the free hormone hypothesis—and tests for it—is operating with information that most men, and many doctors, simply do not have.
References
Cinar, V., Polat, Y., Baltaci, A. K., & Mogulkoc, R. (2011). Effects of magnesium supplementation on testosterone levels of athletes and sedentary subjects at rest and after exhaustion. Biological Trace Element Research, *140*(1), 18–23.
Naghii, M. R., Mofid, M., Asgari, A. R., Hedayati, M., & Daneshpour, M. S. (2011). Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines. Journal of Trace Elements in Medicine and Biology, *25*(1), 54–58.
Naghii, M. R., & Samman, S. (1993). The effect of boron supplementation on its urinary excretion and selected cardiovascular risk factors in healthy male subjects. Biological Trace Element Research, *56*(3), 273–286.
Pizzorno, L. (2015). Nothing boring about boron. Integrative Medicine: A Clinician’s Journal, *14*(4), 35–48.
Round, P., Das, S., Wu, T. S., Wahala, K., Van Petegem, F., & Hammond, G. L. (2020). Molecular interactions between sex hormone-binding globulin and nonsteroidal ligands that enhance androgen activity. Journal of Biological Chemistry, *295*(5), 1202–1211.
